Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Orphan drug status for microplasmin in pediatric eye surgery

April 6, 2004

No Comments

SnET2-PDT NDA submitted for AMD

April 5, 2004

No Comments

Lupin to promote Zymar to U.S. pediatricians

April 2, 2004

No Comments

ThromboGenics and NuVue collaborate on plasmin products for visual disorders

March 16, 2004

No Comments

Iquix receives FDA approval for bacterial corneal ulcer

March 15, 2004

No Comments

VEGF Trap enters clinical development program

March 12, 2004

No Comments

Positive results from Xibrom phase III studies

March 11, 2004

No Comments

Additional phase III data in support of TTFC

March 10, 2004

No Comments

Alrex safe for long-term treatment of seasonal allergic conjunctivitis

Feb. 24, 2004

No Comments

Senju claims new chymase and/or tryptase inhibitors and their use

Feb. 11, 2004

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Orphan drug status for microplasmin in pediatric eye surgery

SnET2-PDT NDA submitted for AMD

Lupin to promote Zymar to U.S. pediatricians

ThromboGenics and NuVue collaborate on plasmin products for visual disorders

Iquix receives FDA approval for bacterial corneal ulcer

VEGF Trap enters clinical development program

Positive results from Xibrom phase III studies

Additional phase III data in support of TTFC

Alrex safe for long-term treatment of seasonal allergic conjunctivitis

Senju claims new chymase and/or tryptase inhibitors and their use

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS